絞り込み

16641

広告

Calcium in the heart: when it's good, it's very very good, but when it's bad, it's horrid.

著者 Roderick HL , Higazi DR , Smyrnias I , Fearnley C , Harzheim D , Bootman MD
Biochem Soc Trans.2007 Nov ; 35(Pt 5):957-61.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, U.K. Llewelyn.roderick@bbsrc.ac.uk

スターを付ける スターを付ける     (185view , 0users)

Full Text Sources

Miscellaneous

Ca(2+) increases in the heart control both contraction and transcription. To accommodate a short-term increased cardiovascular demand, neurohormonal modulators acting on the cardiac pacemaker and individual myocytes induce an increase in frequency and magnitude of myocyte contraction respectively. Prolonged, enhanced function results in hypertrophic growth of the heart, which is initially also associated with greater Ca(2+) signals and cardiac contraction. As a result of disease, however, hypertrophy progresses to a decompensated state and Ca(2+) signalling capacity and cardiac output are reduced. Here, the role that Ca(2+) plays in the induction of hypertrophy as well as the impact that cardiac hypertrophy and failure has on Ca(2+) fluxes will be discussed.
PMID: 17956254 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード